ProductsPricingResearchSupportPartner

Dr. Reddy’s Lab’s Q3FY23 Quarter Results

Dr. Reddy’s Lab’s revenues grew 27% YoY
  • 25 Jan 2023
  • Dr. Reddy’s Lab reported 7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended December (Q3FY23). On a year-on-year (YoY) basis, it witnessed a growth of 27%.
  • Its expenses for the quarter were up by 9% QoQ and 18% YoY.
  • The net profit increased by 12% QoQ and 75% YoY.
  • The earnings per share (EPS) of Dr. Reddy’s Lab stood at 74.8 during Q3FY23.

Dr. Reddy’s Lab’s Financial Statements for Q3FY23:

(Rs, crores) Q1FY22 Q4FY22 Q1FY23 QoQ (%) YoY (%)
Total Income
5,394
6,373
6,849
7%
27%
Total Expenses
4,438
4,773
5,217
9%
18%
Profit before tax
974
1,614
1,638
1%
68%
Tax
265
499
394
-21%
49%
Profit after tax
709
1,114
1,244
12%
75%
Earnings per share
42.7
67.0
74.8

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -